Global Food Amino Acids Market

1 INTRODUCTION OF GLOBAL FOOD AMINO ACIDS MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL FOOD AMINO ACIDS MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework

5 GLOBAL FOOD AMINO ACIDS MARKET, BY SOURCE
5.1 Animal-based
5.2 Plant-based
5.3 Synthetic

6 GLOBAL FOOD AMINO ACIDS MARKET, BY PRODUCT
6.1 Glutamic acid
6.2 Lysine
6.3 Methionine
6.4 Threonine
6.5 Tryptophan
6.6 Leucine
6.7 Iso-leucine
6.8 Valine
6.9 Others

7 GLOBAL FOOD AMINO ACIDS MARKET, BY APPLICATION
7.1 Food & Dietary Supplements
7.2 Pharmaceuticals
7.3 Animal Feed
7.4 Infant Formula
7.5 Others

8 GLOBAL FOOD AMINO ACIDS MARKET, BY GEOGRAPHY
8.1 Overview
8.2 North America Regional Market Estimates and Forecasts, 2012 - 2025
8.2.1 U.S.
8.2.2 Canada
8.2.3 Mexico
8.3 Europe Regional Market Estimates and Forecasts, 2012 - 2025
8.3.1 Germany
8.3.2 U.K.
8.3.3 France
8.3.4 Rest of Europe
8.4 Asia Pacific Regional Market Estimates and Forecasts, 2012 - 2025
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Rest of Asia Pacific
8.5 Latin America Regional Market Estimates and Forecasts, 2012 - 2025
8.5.1 Brazil
8.5.2 Argentina
8.6 Rest of the World Regional Market Estimates and Forecasts, 2012 - 2025

9 GLOBAL FOOD AMINO ACIDS MARKET COMPETITIVE LANDSCAPE
9.1 Overview
9.2 Company Market Share
9.3 Vendor Landscape
9.4 Key Development Strategies

10 COMPANY PROFILES
10.1 Cargill Inc
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments

10.2 Evonik Industries
10.2.1 Overview
10.2.2 Financial Performance
10.2.3 Product Outlook
10.2.4 Key Developments

10.3 Amino GmbH
10.3.1 Overview
10.3.2 Financial Performance
10.3.3 Product Outlook
10.3.4 Key Developments

10.4 Taiyo International
10.4.1 Overview
10.4.2 Financial Performance
10.4.3 Product Outlook
10.4.4 Key Developments

10.5 CJ Corporation
10.5.1 Overview
10.5.2 Financial Performance
10.5.3 Product Outlook
10.5.4 Key Developments

10.6 Kemin Europa
10.6.1 Overview
10.6.2 Financial Performance
10.6.3 Product Outlook
10.6.4 Key Developments

10.7 Sunrise Nutrachem Group
10.7.1 Overview
10.7.2 Financial Performance
10.7.3 Product Outlook
10.7.4 Key Developments

10.8 Royal DSM
10.8.1 Overview
10.8.2 Financial Performance
10.8.3 Product Outlook
10.8.4 Key Developments

10.9 Ajinomoto
10.9.1 Overview
10.9.2 Financial Performance
10.9.3 Product Outlook
10.9.4 Key Developments

10.10 Archer-Daniels-Midland
10.10.1 Overview
10.10.2 Financial Performance
10.10.3 Product Outlook
10.10.4 Key Developments

10.11 Sumitomo Chemical
10.11.1 Overview
10.11.2 Financial Performance
10.11.3 Product Outlook
10.11.4 Key Developments

10.12 Adisseo
10.12.1 Overview
10.12.2 Financial Performance
10.12.3 Product Outlook
10.12.4 Key Developments

10.13 Changzhou Yabang Chemical
10.13.1 Overview
10.13.2 Financial Performance
10.13.3 Product Outlook
10.13.4 Key Developments

10.14 Sunrise Nutrachem Group
10.14.1 Overview
10.14.2 Financial Performance
10.14.3 Product Outlook
10.14.4 Key Developments

10.15 Kyowa Hakko Bio
10.15.1 Overview
10.15.2 Financial Performance
10.15.3 Product Outlook
10.15.4 Key Developments

10.16 Iris Biotech
10.16.1 Overview
10.16.2 Financial Performance
10.16.3 Product Outlook
10.16.4 Key Developments

10.17 Global Bio-chem Technology Group
10.17.1 Overview
10.17.2 Financial Performance
10.17.3 Product Outlook
10.17.4 Key Developments

10.18 Fufeng Group
10.18.1 Overview
10.18.2 Financial Performance
10.18.3 Product Outlook
10.18.4 Key Developments

10.19 Daesang
10.19.1 Overview
10.19.2 Financial Performance
10.19.3 Product Outlook
10.19.4 Key Developments

10.20 Glanbia Nutritionals
10.20.1 Overview
10.20.2 Financial Performance
10.20.3 Product Outlook
10.20.4 Key Developments

11 Appendix
11.1 Related Reports